Kisqali 200 MG daily dose UU 21S
Ended Awarded
- Contract number
- SPE2DB25FNWML
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,892
Award facts
- Contract value 100% obligated
- $16,892.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $16,892.30, was awarded on September 15, 2025, to AmerisourceBergen Drug Corp for the supply of KISQALI 200 mg daily dose (21-unit package). The contract is a firm fixed-price delivery order with no set-aside designation, issued by the Defense Logistics Agency under the Department of Defense. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. KISQALI (ribociclib) is a cyclin-dependent kinase inhibitor used in oncology treatment, reflecting the breadth of pharmaceutical products distributed through federal medical supply channels.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains significant federal contracting relationships and serves critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts demonstrating the company's capability to meet rigorous federal procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FNWML?
SPE2DB25FNWML was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNWML worth?
The government has obligated $16,892 on SPE2DB25FNWML.
Is contract SPE2DB25FNWML an order under another contract?
Yes. SPE2DB25FNWML is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWML competed?
The extent of competition for SPE2DB25FNWML was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award